Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Desmopressin : safety considerations in patients with chronic renal disease.

× No keyword cloud information.

21 in total

1. Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure.

Authors: Hana Ruzicka; Sven Björkman; Stefan Lethagen; Gunnar Sterner
Journal: Pharmacol Toxicol Date: 2003-03

2. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years.

Authors: Asa Rembratt; Charlotte Graugaard-Jensen; Thomas Senderovitz; Jens Peter Norgaard; Jens Christian Djurhuus
Journal: Eur J Clin Pharmacol Date: 2004-06-09 Impact factor: 2.953

Review 3. Hemostatic drugs.

Authors: P M Mannucci
Journal: N Engl J Med Date: 1998-07-23 Impact factor: 91.245

Review 4. Uremic bleeding: pathophysiology and clinical risk factors.

Authors: Avtar S Sohal; Azim S Gangji; Mark A Crowther; Darin Treleaven
Journal: Thromb Res Date: 2005-07-01 Impact factor: 3.944

5. Reduced response of uraemic bleeding time to repeated doses of desmopressin.

Authors: C Canavese; M Salomone; A Pacitti; G Mangiarotti; V Calitri
Journal: Lancet Date: 1985-04-13 Impact factor: 79.321

6. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.

Authors: Norman M Wolfish; Jack Barkin; Fabian Gorodzinsky; Robert Schwarz
Journal: Scand J Urol Nephrol Date: 2003

7. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.

Authors: Henrik Agersø; Lotte Seiding Larsen; Anders Riis; Ulf Lövgren; Mats O Karlsson; Thomas Senderovitz
Journal: Br J Clin Pharmacol Date: 2004-10 Impact factor: 4.335

8. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.

Authors: P M Mannucci; Z M Ruggeri; F I Pareti; A Capitanio
Journal: Lancet Date: 1977-04-23 Impact factor: 79.321

9. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).

Authors: P M Mannucci; D Bettega; M Cattaneo
Journal: Br J Haematol Date: 1992-09 Impact factor: 6.998

10. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

Authors: P M Mannucci; G Remuzzi; F Pusineri; R Lombardi; C Valsecchi; G Mecca; T S Zimmerman
Journal: N Engl J Med Date: 1983-01-06 Impact factor: 91.245

1 in total

Review 1. Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?

Authors: Nishank Jain; S Susan Hedayati; Ravindra Sarode; Subhash Banerjee; Robert F Reilly
Journal: Clin J Am Soc Nephrol Date: 2012-09-27 Impact factor: 8.237

1 in total